Biologics Outsourcing Market Estimated To Be Valued Propelled By Increasing Demand For Cost-Effective Drug Development
Biologics such as monoclonal antibodies, recombinant proteins, and stem cell & gene therapies have revolutionized the treatment of various chronic and life-threatening diseases. However, high development costs associated with biologics hamper widespread accessibility and adoption. Outsourcing drug development activities such as preclinical and clinical research, laboratory testing, and...
0 Комментарии
0 Поделились